H ypertension is a common condition that according to a global study will affect 1.56 billion adults by the year 2025. 1 Despite this, essential hypertension (EH) remains as a complex phenotype in which genetic determinants remain largely undefined. 2,3 A recent large study of Sardinian families estimated a broad-sense heritability of ≈65% and ≈45% for systolic and diastolic blood pressure (BP), respectively. 4 In general, large-scale epidemiological studies suggest that the heritability of BP exceeds 50%, justifying a search for genetic variants influencing susceptibility to EH. 5,6 Indeed, the human genome contains several genetic variants that may influence the BP and have been associated with hypertension. 7, 8 In this regard, the AGTRAP-MTHFR-CLCN6-NPPA-NPPB gene cluster at 1p36 has been associated with cardiac dysfunction, BP, and renal disease. 2, [9] [10] [11] MTHFR is a key element within this gene cluster that codifies for the enzyme methylenetetrahydrofolate reductase, which catalyzes the reduction of 5,10-methylenetetrahydrofolate to 5 methyltetrahydrofolate, a cosubstrate Background-Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) have been associated with diastolic blood pressure, hypertension, and other cardiovascular diseases; however, results of these studies are still controversial. In this study, we sought to determine whether 2 functional variants (rs1801133 and rs13306560) within the MTHFR are associated with hypertension in Mexican-Mestizos. Methods and Results-We performed a case-control study with 1214 subjects including adults and children to test for the association of both single nucleotide polymorphisms with essential hypertension. The adult group included 764 participants (372 patients and 391 controls) and the group of children included 418 participants (209 patients and 209 controls). rs13306560 was associated with essential hypertension in adults (odds ratio, 4.281; 95% confidence interval, 1.841-9.955; P=0.0003) with a statistical power >0.8. In children, none of the polymorphisms was associated with essential hypertension. In addition, we assessed the effect of the rs13306560 polymorphism on the MTHFR promoter region by means of luciferase reporter gene assays using human umbilical vein endothelial cells. Cells transfected with the pMTHFRaLUC construct showed an ≈25% reduction in luciferase activity (P=0.003). Furthermore, the promoter activity was reduced considerably by in vitro methylation of CpG sequences. Conclusions-Our data suggest that the rs13306560 polymorphism of the MTHFR may be part of the observed hypertension process in Mexican-Mestizo populations, but further studies are warranted. In addition, the allele A of the rs13306560 polymorphism as well as the in vitro methylation of CpGs reduced the promoter activity of the MTHFR regulatory region. (Circ Cardiovasc Genet. 2015;8:603-609.
for homocysteine remethylation to methionine. 12 The T allele of the rs1801133 (formerly C677T or A222V) generates an MTHFR thermolabile enzyme with reduced activity, and the homozygous state of this allele has been associated with a moderately elevated plasma homocysteine level. 13, 14 It has been proposed that hyperhomocysteinemia induces oxidative injury of vascular endothelial cells, arteriolar constriction, renal dysfunction, and increased sodium reabsorption. [15] [16] [17] Results of 2 meta-analyses suggest that the MTHFR C677T polymorphism is associated with an increased risk of hypertension, at least in Asian and white populations. 18, 19 Our group previously found that the 677TT genotype is associated with a reduced risk of preeclampsia in Maya-Mestizo women. 20 However, no study has examined the possible association of this polymorphism with EH in Mexican-Mestizo populations.
Moreover, Tomaszewski et al. 10 described another polymorphism (rs13306560) located in the promoter region of MTHFR/CLNC6 that has a strong association with diastolic BP and proposed by in silico analysis the potential functionality of this variant. Furthermore, the research group suggested that this polymorphism is associated with BP independently of the thermolabile form of MTHFR generated by the 677T allele of the rs1801133. This is supported by the observations that the rs13306560 is not in linkage disequilibrium with rs1801133 and that this has a minor association with diastolic BP. 10 Despite this, there are no published studies seeking the association of the rs13306560 with EH.
Therefore, the aim of this study was to gain insight on the potential role of rs1801133 and rs13306560 in EH in Mexican-Mestizo adults and children as well as to determine by in vitro studies the functionality of the rs13306560.
Methods

Subjects
The study was approved by the Institute's Human Research and Ethics Committees. All participants provided written informed consent before inclusion in the study. A case-control association study was performed. There were 1181 individuals (763 adults and 418 children) admitted into the study. Mexican ancestry was considered as Mexican-Mestizo individuals born in Mexico and who have a Spanish-derived last name and can be traced back to the third generation. 21 The adult group included 372 patients with EH referred to the National Institute of Cardiology (INCICH) in Mexico City and 391 normotensive individuals recruited among blood donors at the INCICH with systolic and diastolic BPs <120 and <80 mm Hg, respectively, and not taking any antihypertensive medications. Hypertension was defined as systolic BP ≥140 mm Hg, diastolic BP ≥90 mm Hg, or the use of at least 1 class of antihypertensive drugs. Secondary hypertension was ruled out using a detailed health questionnaire and clinical evaluation. None of the patients had evidence of cardiac or renal failure. Furthermore, all individuals were evaluated for various clinical characteristics as previously reported. 22 In regard to the group of children, we included 418 unrelated school-age Mexican-Mestizo children of whom 209 were hypertensive and 209 were nonhypertensive. In this case, each hypertensive child was age-and sex-matched with a nonhypertensive child. The definition of hypertension in children and adolescents was in concordance with the criteria previously reported with a basis on the normative distribution of BP in healthy children. 23 Children with prehypertension and stage 1 and 2 hypertension were included in the case group (Table 1 ). In addition, several anthropometric and biochemical parameters were measured in all individuals as described in a previous study. 24
Genotyping and Quality Control
Genomic DNA was isolated from peripheral blood using a commercial kit based on the salt fractionation method (QIAmp 96 DNA Blood Kit, Qiagen, Hilden, Germany). The rs1801133 and rs13306560 single nucleotide polymorphisms were genotyped using 5′ TaqMan genotyping assays (Applied Biosystems, Foster City, CA; assay ID: C___1202883_20 and C___30914969_10) on a LightCycler 480 Instrument (Roche Diagnostics Ltd, Basel, Switzerland) according to the manufacturer's instructions. Genotyping call rate surpassed 95% for all single nucleotide polymorphisms tested, with no discordant genotypes in 10% of duplicate samples.
Constructs and Plasmids
A 563-bp DNA fragment of the MTHFR regulatory sequence (−441/+122) was polymerase chain reaction amplified from DNA of a heterozygous patient for the rs13306560 variant. Oligonucleotides used to amplify the promoter sequence were forward: KpnI/MTHFR F GCGC GGTACC ggaggggttatgagaaaagacc and reverse: HindIII/ MTHFR R GCGC AAGCTT gtgtcaggttgctggagagg. polymerase chain reaction conditions were as follows: 1 cycle at 95°C for 3 minutes, 31 cycles at 95°C for 45 s, 62°C for 30 s, 72°C for 30 s, and a final extension at 72°C for 7 minutes. Amplified DNA was cloned in the pGEM-T Easy (Promega, Madison, WI) and sequenced using a dye terminator cycle sequencing reaction kit (ABI PRISM 310, Applied Biosystems, Foster City, CA). Clones containing allele G or A of the rs13306560 were subcloned into the KpnI/HindIII sites of pGL3-basic (Promega) containing luciferase reporter gene and sequenced using a dye terminator cycle sequencing reaction kit (ABI PRISM 310, Applied Biosystems).
In Vitro Methylation
Ten micrograms of the assessed vectors was methylated in vitro with the CpG methyltransferase (M. SssI, New England Biolabs, Ipswich, MA) according to the manufacturer's instructions and the protocol described by Mamrut et al. 25 The effectiveness of methylation was examined by digestion of an aliquot with methylation-sensitive SsiI restriction enzyme.
Cell Culture, Transfection, and Reporter Gene Activity Analysis
HUVECs were isolated from human umbilical cord segments and cultured as previously reported. 26 Two hundred thousand cells corresponding to 90% confluence were seeded in 9.5 cm 2 culture wells; cells were transfected 48 hours later using Lipofectamine 2000 (Invitrogen, Life Technologies, Carlsbad, CA) according to the manufacturer's instructions. One microgram of each MTHFR The percentiles were calculated for each group as described in Methods 20 and only the highest and lowest percentiles of each group are indicated. DBP indicates diastolic blood pressure; and SBP, systolic blood pressure.
promoter construct was transiently cotransfected with 250 ng of pRL/CMV (Promega) plasmid used to normalize luciferase activities. Luciferase activity in transfected HUVECs was measured 48 hours post transfection using the DualLuciferase Reporter Assay System (Promega) according to the manufacturer's instructions in a TD-20/20 luminometer (Turner Designs, Sunnyvale, CA). Luciferase activity was then normalized to the protein concentration of each cell lysate.
Statistical Analysis
Demographic and clinical variables between hypertensive and nonhypertensive groups were analyzed using SPSS v. 16 .0 (SPSS Inc, Chicago, IL). Numeric variables not normally distributed are presented as median and range and were compared using the Mann-Whitney U test. Comparisons between categorical variables and deviations from Hardy-Weinberg equilibrium were performed using χ 2 test. Normally distributed numeric variables are presented as mean±SD and compared using the Student t test.
A multivariable logistic regression analysis was used to test the associations between genotype and hypertension under additive, dominant, and recessive inheritance models, reporting the most significant. Odds ratio and P value were adjusted for Z score body mass index, triglycerides, and cholesterol in children; glucose, triglycerides, type 2 diabetes mellitus, and family history in adults.
In the case of rs13306560 with low genotype counts, Fisher exact test was also used to evaluate the association between genotype and hypertension. A 2-way nonparametric ANOVA was used to evaluate the effect of the rs13306560 alleles and the in vitro CpG methylation on the promoter activity of regulatory cloned sequence of the MTHFR gene.
Statistical power to detect an association of rs13306560 and rs1801133 with hypertension at an α of 0.05 was calculated taking into account the frequencies of the polymorphisms and the prevalence of hypertension in the childhood and adult populations, 27, 28 in addition to other parameters (Table 2) , under an additive model using QUANTO software (http://hydra.usc.edu/GxE/).
Results
Characteristics of the Studied Populations
Clinical and demographic characteristics of patients and controls of both studied populations are shown in Table 3 . With regard to children, Z score of body mass index, triglycerides, and cholesterol was significantly higher in the group with EH than in nonhypertensive individuals. The other characteristics were not significantly different between groups.
In the adult groups, individuals with EH showed significantly higher levels of triglycerides and glucose as compared with the levels observed in nonhypertensive individuals. They also showed significant differences in family history and diabetes mellitus. The other characteristics were not significantly different between groups ( Table 3 ).
Association of rs1801133 and rs13306560 With EH
Hardy-Weinberg equilibrium test was performed for the polymorphisms under study. The distribution of the observed genotypes did not differ from what was expected in either the patient or control groups (P>0.05).
Allele and genotype frequencies of the rs13306560 and rs1801133 polymorphisms are presented in Tables 4 and  5 , respectively. In children, there was no association of the polymorphism rs1801133 (C-677T→A222V) with EH under additive model (odds ratio [OR], 1.111; 95% confidence interval, 0.822-1.503; P=0.4925) and any other model used. In contrast, in the adult population, under the additive model, the MTHFR 677TT+TC genotypes conferred with low significance a decreased risk of hypertension (OR, 0.768; 95% confidence interval, 0.624-0.947; P=0.0133) after adjusting by glucose, triglycerides, type 2 diabetes mellitus, and family history, with a statistical power of 0.763 according to the OR obtained.
About polymorphism rs13306560, in children it was not significantly associated with hypertension (OR, 2.706; 95% confidence interval, 0.947-7.732; P=0. 0891). In adults, the presence of the allele MTHFR −23A (at −23 bp of the transcription star site, sequence accession number: NG_008766; Figure [ A]) was associated, under the additive model, with an increased risk of hypertension (OR, 4.281; 95% confidence interval, 1.841-9.955; P=0. 0003).
Bioinformatic Analysis
To gain insight into the possible implications of the rs13306560 polymorphism in the MTHFR promoter, we used the MatInspector software that uses a wide library of matrix descriptions for transcription factor binding sites in DNA sequences. The analysis showed that the polymorphism is adjacent to a site for Krüppel-like transcription factors (Figure [A] ) whose activity may be differently affected depending on the allele present.
In Vitro Functionality of rs13306560
Because the rs13306560 is located in the putative core promoter of the MTHFR (Figure [A] ), we decided to examine the effect of either allele G or A on the promoter activity. To this end, we transfected HUVECs with a luciferase reporter gene construct harboring the MTHFR promoter sequence with the G or A allele of the rs13306560. Cells transfected with the construct pMTHFRaLUC showed an ≈25% reduction in luciferase activity (P=0.003) compared with those transfected with pMTHFRgLUC (Figure [B] ). A similar result was obtained when the experiment was performed in human umbilical vein smooth muscle cells (data not shown). However, a computational-based analysis by Tomaszewski et al 10 and by our group showed the presence of a CpG island in the regulatory sequence of the MTHFR/CLCN6, opening the possibility of DNA methylation as a mechanism for gene expression regulation. To explore this, we methylated in vitro the 2 clones containing the promoter of MTHFR with each allele of the rs13306560 polymorphism (Figure) . In both cases, the expression level of the reporter gene was diminished almost to the level of the negative control.
Discussion
In this study, we analyze the presence of the association of rs13306560 and rs1801133, located in the promoter region and exon 4 of the MTHFR, respectively, in children and adults with and without EH. With regard to the childhood population, we found no association of the rs1801133 (C677T) polymorphism with EH. A similar effect has been reported in a study conducted with Chinese hypertensive children. 29 However, in the adult population, there was a low significant protective effect of allele 677T, which contrasts with previous reports associating the 677TT genotype with an increased risk of hypertension in Asian, white, and Chinese populations. 18, 19 In a previous study, we observed a protective effect of the 677TT genotype with preeclampsia in Maya-Mestizo women. 20 The presence of the 677T allele of the MTHFR produces a thermolabile enzyme because of the presence of a valine residue instead of an alanine residue in the amino acid sequence of the protein, which has been associated with a high level of total homocysteine in plasma. 13, 30 However, a study performed in subjects from Mexico City reported one of the highest frequencies of the 677T allele and no correlation of the TT homozygous genotype with total homocysteine levels. 31 In addition, these investigators proposed that high folic acid intake because of the Mexican diet may exert a positive selection on the TT genotype. Consistent with this hypothesis, a previous study by our group showed that several Mexican Amerindian populations have the highest reported frequency of the 677T allele. 32 About the rs13306560 polymorphism, an extensive study with European nuclear families showed that this variant, located in the MTHFR/CLCN6 locus, is strongly associated with diastolic BP. 10 In this study, we found a risk association trend between the −23A allele and hypertension in the childhood population. Concerning the adult populations, the −23A allele was significantly associated with an increased risk of EH under an additive model. The associated differences observed between the 2 populations may be ascribed to the exposure time of the individuals to different factors that modified BP, such as physical activity, dietary salt intake, alcohol use, smoking habit, age, and body mass index. 33 Based on this premise, individuals with the risk allele who are exposed to several environmental risk factors may have an increased possibility of developing EH. Furthermore, it is important to underline that the selection criteria were different between adults and children. In the first case, individuals were selected from patients who arrived at the hospital for treatment; in the second case, the samples were obtained from a group recruited from a summer camp for children of employees of the Mexican Health Ministry and from a public junior high school in Mexico City. 24 Bioinformatic analysis has suggested the functionality of the rs13306560 polymorphism and that the ancestral allele G is conserved in higher vertebrates. 7 Additional analysis conducted by our group showed that this polymorphism is located at −23 bp from the transcription start site, a segment that may be within the basal promoter of the MTHFR. Interestingly, the presence of the −23A allele reduced, in ≈25%, the promoter activity of the regulatory sequence cloned to direct the expression of the luciferase gene as compared with the clone that harbored the −24G allele. Patients with EH presented a higher frequency of the allele A. Consequently, individuals with this allele may have a reduced expression of the MTHFR transcript and the concomitant diminution of the protein level. It is possible that because of this effect the −23A allele is mediating its association with EH. According to other computational analyses, the rs13306560 polymorphism is adjacent to a consensus site for Krüppel-like factors. Because of this, it may be hypothesized that the presence of every allelic variant affects differentially the activity of this site. In this regard, Krüppellike factors regulate the transcription of some genes by recruiting other transcription factors, chromatin remodelers, and transcription machinery to specific promoters. 34 Likewise, the rs13306560 polymorphism is located within a region containing a CpG island found in the intergenic union of MTHFR and CLCN6. 7 Considering this, we observed that the in vitro methylation of the MTHFR regulatory sequence drastically reduced the expression of the luciferase reported gene regardless of the rs13066560 allele present in the promoter. In this sense, the degree of methylation of the regulatory sequence could be another factor that determines the level of expression of the MTHFR. Kerkel et al. 35 proposed that methylation of some regulatory sequences may be determined according to some dimensions by specific single nucleotide polymorphisms. In addition, epigenetic mechanisms have been associated with the development of hypertension. 36, 37 Epigenesis is another factor that may explain the observed differences in genetic association between children and adults with polymorphism rs13066560 because a shorter exposure to environmental factors may be associated with fewer epigenetic changes. Therefore, it may be relevant to test in future investigations whether the rs13066560 polymorphism has influence over the methylation of the CpG islands located in the MTHFR/CLCN6 regulatory sequence. Interestingly, a study by Crider et al 38 showed that the CC genotype of rs1801133 variant was associated with hypomethylation under folate depletion. In view of this, a possible effect of both rs13066560 and rs1801133 in MTHFR/CLCN6 RNA and protein level via genetic or epigenetic mechanisms remains to be proven.
In relation to CLCN6, the polymorphism is located in the 5′UTR (untranslated region) at +31 bp of the transcription start site, using as a reference the reported sequences of the CLCN6 (accession number: NG_008766). Flister et al, 2 using a genetically modified murine model, showed that the Clcn6 gene plays a relevant role in BP modulation. Accordingly, the rs13306560 variant could mediate its association with EH, modifying the expression of both MTHFR and CLN6. Further studies are needed to confirm this hypothesis.
In summary, our results propose that rs13306560 may play a role in the development of EH in the Mexican-Mestizo population because the polymorphism was associated with an increased risk of the disease. In addition, we determined that this polymorphism affects the promoter activity of the regulatory sequence of the MTHFR and that this promoter capacity is drastically reduced by in vitro CpG methylation. Additional studies are needed to evaluate whether the polymorphisms also affect the expression level of the CLCN6 and whether epigenetic mechanisms on the MTHFR/CLCN6 regulatory sequences may be involved in the development of EH. Figure. rs13306560 affects the promoter activity of MTHFR regulatory sequence. A, Schematic diagram of the MTHFR promoter indicating the presence of both allelic variants (−24, G/C) and the consensus sequence for Kruppel-like factor. The promoter sequence with each allele was cloned in pGL3 vector to direct the expression of the luciferase gene as described in Materials and Methods. B, The presence of allele A (pMTHFRaLUC) reduces the promoter activity of the sequence in ≈25% as compared with the promoter activity observed in cells transfected with the MTHFR regulatory sequence harboring the allele G (pMTHFRgLUC) (*P=0.0007). Methylation of both clones drastically reduced the activity of the promoter independently of the allele present ( † P˂10 -4 ). n=5 independent duplicate experiments; mean values were compared by 2-way nonparametric ANOVA.
